Anti-ischemic effect of 2-week cycle of heparin plus exercise-to-ischemia twice daily in patients with "no-option" angina: the CARHEXA trial
1 September 2019 (14:00 - 18:00)
Organised by:
Abstract
About the speaker

University of Pennsylvania, Philadelphia (United States of America)
12 More presentations in this session
Access the full session
The Event
ESC Congress 2019
1 September 2019
14:00 CET
